vimarsana.com
  1. Home
  2. Live Updates
  3. Dyne Therapeutics Receives FDA Orphan Drug Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1 : vimarsana.com

Dyne Therapeutics Receives FDA Orphan Drug Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1

Dyne Therapeutics Receives FDA Orphan Drug Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Wildon Farwell ,Amy Reilly ,Stacy Nartker ,Facebook ,Exchange Commission ,European Medicines Agency ,Twitter ,Linkedin ,Dyne Therapeutics Inc ,Nasdaq ,Drug Administration ,Report Initial Data ,Multiple Ascending Dose Phase ,Second Half ,Dyne Therapeutics ,Orphan Drug Act ,Myotonic Dystrophy Type ,Private Securities Litigation Reform Act ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.